IMAX Insider Notice: 20,000 RSU Shares Filed for Sale on 09/15/2025

Rhea-AI Filing Summary

IMAX Corp filed a Form 144 to notify a proposed sale of 20,000 Class A Common Shares through Merrill Lynch on the NYSE with an approximate sale date of 09/15/2025. The filing reports an aggregate market value of $656,029 against 53,782,520 shares outstanding, indicating the sale represents a small fraction of the company's outstanding stock.

The 20,000 shares were acquired through vesting of restricted stock units (RSUs) issued as compensation on dates between 02/21/2018 and 03/07/2021 (2,456; 1,869; 15,203; 472 respectively). No securities sales by the filer in the past three months are reported, and the filer certifies no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for 20,000 vested RSU shares, immaterial relative to outstanding shares.

The Form 144 documents a proposed sale of 20,000 Class A shares via Merrill Lynch, valued at $656,029, against 53.78 million shares outstanding (≈0.037% of outstanding). The securities were received from RSU vesting between 2018 and 2021, confirming compensation-originated holdings rather than a secondary issuance. No recent sales in the prior three months are reported by the filer. This is a standard compliance filing and likely neutral for IMAX's near-term market dynamics.

Corporate Governance Expert

TL;DR: Compliance disclosure of an insider's planned sale; disclosure aligns with Rule 144 requirements.

The notice provides required information: broker, share count, market value, acquisition history and compensation origin (RSU vesting). The filer represents no undisclosed material adverse information and there is no indication of reliance on a 10b5-1 plan in the filing. From a governance perspective, the form meets disclosure obligations; the transaction size appears immaterial to shareholder control or dilution.

FAQ

What did IMAX's Form 144 report?

The filing reports a proposed sale of 20,000 Class A Common Shares through Merrill Lynch with an approximate sale date of 09/15/2025 and aggregate market value of $656,029.

How many IMAX shares outstanding are referenced in the Form 144?

The filing lists 53,782,520 shares outstanding, so the proposed sale represents about 0.037% of outstanding shares.

How were the 20,000 IMAX shares acquired?

All 20,000 shares were acquired via vesting of restricted stock units (RSUs) as compensation on dates between 02/21/2018 and 03/07/2021 (2,456; 1,869; 15,203; 472).

Did the filer report any sales in the past three months?

The filing states Nothing to Report for securities sold during the past three months by the person for whose account the securities are to be sold.

Which broker and exchange are being used for the proposed sale?

The broker is Merrill Lynch One Bryant Park, New York and the securities exchange named is the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/15/2025 - 04:00 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001255900
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corp
SEC File Number	001-35066
Address of Issuer	902 Broadway FL 20 New York NEW YORK 10010
Phone	2128210142
Name of Person for Whose Account the Securities are To Be Sold	Robert D. Lister
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common Shares	Merrill Lynch One Bryant Park, 28th Floor New York NY 10036	20000	656029	53782520	09/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	02/21/2018	Vesting of RSU	Issuer			2456	02/21/2018	Compensation
Class A Common	03/07/2018	Vesting of RSU	Issuer			1869	03/07/2018	Compensation
Class A Common	03/07/2019	Vesting of RSU	Issuer			15203	03/07/2019	Compensation
Class A Common	03/07/2021	Vesting of RSU	Issuer			472	03/07/2021	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/15/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/11/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Robert D Lister
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)